Nautilus Biotechnology IncNASDAQ:NAUT
No Matches were found for
- LAST PRICE2.7300
- TODAY'S CHANGE (%)0.0300 (1.1111%)
- Bid / Lots2.6900/ 10
- Ask / Lots2.9600/ 1
- Open / Previous Close2.6800 / 2.7000
- Day Range
- 52 Week Range
- Volume53,111
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NAUT |
|---|---|---|
| 09:32 ET | 806 | 2.68 |
| 09:39 ET | 1700 | 2.7137 |
| 09:59 ET | 429 | 2.695 |
| 10:01 ET | 134 | 2.68 |
| 10:10 ET | 700 | 2.7099 |
| 10:12 ET | 300 | 2.685 |
| 10:15 ET | 100 | 2.6813 |
| 10:21 ET | 1200 | 2.6832 |
| 10:35 ET | 2698 | 2.7093 |
| 10:37 ET | 4800 | 2.7057 |
| 10:42 ET | 100 | 2.71 |
| 10:50 ET | 100 | 2.72 |
| 11:33 ET | 100 | 2.72 |
| 11:38 ET | 259 | 2.73 |
| 11:40 ET | 828 | 2.71 |
| 12:00 ET | 100 | 2.73 |
| 12:30 ET | 1000 | 2.74 |
| 12:56 ET | 100 | 2.72 |
| 01:10 ET | 100 | 2.75 |
| 01:17 ET | 100 | 2.72 |
| 01:39 ET | 107 | 2.7182 |
| 01:50 ET | 100 | 2.72 |
| 01:55 ET | 100 | 2.71 |
| 02:02 ET | 100 | 2.73 |
| 02:08 ET | 100 | 2.73 |
| 02:15 ET | 100 | 2.73 |
| 02:18 ET | 200 | 2.716651 |
| 02:31 ET | 100 | 2.73 |
| 02:44 ET | 200 | 2.73 |
| 02:45 ET | 100 | 2.73 |
| 02:51 ET | 100 | 2.73 |
| 02:56 ET | 100 | 2.71 |
| 03:00 ET | 100 | 2.73 |
| 03:07 ET | 100 | 2.73 |
| 03:09 ET | 100 | 2.71 |
| 03:20 ET | 100 | 2.73 |
| 03:23 ET | 1571 | 2.72 |
| 03:27 ET | 200 | 2.73 |
| 03:34 ET | 100 | 2.73 |
| 03:36 ET | 100 | 2.74 |
| 03:39 ET | 100 | 2.74 |
| 03:41 ET | 100 | 2.74 |
| 03:45 ET | 900 | 2.74 |
| 03:48 ET | 100 | 2.77 |
| 03:50 ET | 100 | 2.77 |
| 03:52 ET | 244 | 2.74 |
| 03:59 ET | 18554 | 2.73 |
Sep 17, 2024
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer, from 8:00AM ET on Tuesday Sep 17, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 17, 2024 by Dow JonesPress Release: Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer, from 8:00AM ET on Tuesday Sep 17, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nautilus Biotechnology Inc | 342.4M | -4.9x | --- |
Climb Bio Inc | 342.7M | -2.4x | --- |
Monte Rosa Therapeutics Inc | 330.8M | -2.4x | --- |
Corvus Pharmaceuticals Inc | 330.3M | -11.8x | --- |
GH Research PLC | 328.8M | 0.0x | --- |
Biomea Fusion Inc | 366.8M | -2.6x | --- |
Company Information
No data available
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $342.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 125.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.03 |
EPS | $-0.56 |
Book Value | $2.12 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
